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Abstract 
 
Israel figures among the world-leaders in R&D expenditure and has a high-performing 
scientific community. Since the 1990s it has been associated with the Scientific Policy of 
the European Union via the European Research Framework Programmes (FP). The 
cooperation between Israel and the EU in this domain has gradually increased and 
benefits the scientific communities on both sides.  In 2014 the association of Israel to the 
latest and biggest European FP ever adopted (Horizon 2020) was renewed for the fourth 
time. Based on all the scientific evidence provided, the elaboration of a European Research 
Policy can be identified as a highly regulated domain, offering relevant ‘channels of 
influence’.  
These channels offer Israel the opportunity to act within the Research Policy system. 
Being a member of several formal EU bodies in charge of implementing EU Research 
Policy, Israel is able to introduce its positions effectively. This is accompanied by an 
outstanding level of activity by Israel in linking concrete EU Research Policy measures to 
the Israeli Scientific Community at the national level. To carry out this task, Israel relies on 
an effective organization, which remodels the provided EU structures: European ‘National 
Contact Points’ (NCPs) are concentrated within the ‘Europe Israel R&D Directorate’ 
(ISERD). ISERD connects efficiently all the relevant actors, forums and phases of EU-Israeli 
Research Policy. ISERD can be recognized as being at the heart of Israel's research 
cooperation with the EU, and its structure may be a source of inspiration for other policy 
domains involving European cooperation with non-EU states.   
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Since the association of Israel to the European Research Framework Programmes1 
(FP) in the 1990s, the EU-Israeli cooperation in the domain of research has gradually 
increased. The benefits for the scientific community on both sides are considerable, and 
the association of Israel to the latest and biggest European FP ever adopted (Horizon 
2020) was renewed recently. More generally, “the cooperation between Israel and the EU 
on research and innovation is a key element of our broader relations”, as certified by 
former European Commissioner for Research Máire Geoghegan-Quinn.2 Israel gained 
efficiency and a presence in European research activities comparable to that of the most 
performing Member States of the European Union (MSEU). Further, the high return on 
investments generated for Israel makes its participation in the European FP a notable 
economic issue.3 This consideration raises the question if Israel's interests in the field of 
research and innovation policies are organized at European level. And for the cases in 
which they are, how are they organized?  
With this research question in mind, the following analysis aims at shedding light 
on a domain where a lack of information often plays in favor of diffused preconceptions.4 
Interest groups5 are necessary for the well-functioning of the EU political process and are 
recognized for their substantial role in their interactions with the European institutions.6 
On one hand, interest groups address a legitimacy gap between the European institutions 
and the European citizens;7 on the other hand, interest groups play the role of an 
indispensable channel of expertise beneficial to the European institutions.8 This paper 
therefore tests the following hypothesis: Regarding the high interests at stake for Israel in 
the domain of research cooperation on one hand, and the openness of the Commission for 
external interests on the other hand, Israel’s interests in the domain of research are likely 
1 To avoid confusions, this paper adopts the English spelling for 'Programme' as used in the official 
documents of the European Commission.  
2 ISERD, ‘Horizon 2020 – The European R&D Programme Takes Off’, ISERD – The Israel-Europe R&D 
Directorate, 2014, retrieved on 14.04.2015: http://www.iserd.org.il/_Uploads/dbsAttachedFiles/ 
ISERD_EN.pdf., p. 2. 
3 The return on Investment is at around 60%. See: Chapter II. 
4  See I particular the books and blog of David Cronin: retrieved on 5.05.2015: http:// 
dvcronin.blogspot.be/2010/11/how-israel-lobby-dictates-eu-policy.html. 
5 Interest groups, interest representations, and lobbying groups  are used interchangeably.  
6 J. Greenwood, Interest Representation in the European Union, New York, Palgrave Macmillan, 2011, 
3rd ed., p. 3. 
7 V. Schmidt, ‘Democracy and Legitimacy in the European Union Revisited: Output, Input and 
Throughput’ in: KFG Working Paper Series, No. 21, November 2010, Kolleg-Forschergruppe (KFG) 
“The Transformative Power of Europe“, Freie Universität Berlin. 
8 J. Greenwood, op. cit. 
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to be represented at the European level. Lying at crossroads between interest 
representation in the EU, European Research Policy and Israel-EU relations, the analysis 
enters ‘terra incognita’. As introduced in the research question, this analysis will 
concentrate on the identification of actors and structures and not on strategies or 
methods of Israel's interest representation. The topic will be addressed in three 
consecutive steps. First, the general context of research policies and spending in the EU 
and in Israel will be addressed to provide the necessary knowledge base. Second, 
emphasis will be put on the European Research Policy, with the aim to identify ‘channels 
of influence’. These channels of influence, subsumed in a general ‘model on influencing 
European research policy’, will serve as indicators for the identification of Israel's interest 
groups in a third step. This approach underlies the supposition that Israel is a rational 
actor which - for the case it is present in Brussels in research policy fields - will be present 
close to those channels where influence is possible. The research is based on qualitative 
interviews as well as on quantitative empirical analysis. 
 
1. Research Matters: Research and Innovation in the EU and Israel 
Generally speaking, EU spending in research and innovation (R&I) is part of a 
broader approach targeted on growth and innovation, benefiting the technological and 
industrial dimensions of research.9 The overall spending of the Union in research and 
innovation has consistently increased since the launch of the policy and amounts to €78.6 
bn under the H2020 Research Framework Programme (compared to €50.5 bn for the 7th 
Research Framework Programme (FP7)).10 The remote target of the EU to dedicate 3% of 
GDP to R&I was not reached under the Lisbon Strategy, and it remains to be seen if it will 
be reached under Europe 2020, the current percentage stagnating at around 2,1%.11  
In order to implement the strategies and policies above, take charge of the 
distribution of the funding of its FP, and contribute to a better linkage of European 
sciences projects, numerous research-related organizations, agencies or projects are 
attributed their own specific role. The multiplicity of actors, the most important ones being 
9 'Research and Innovation' (R&I) is a term specific to the European Commission and covers 
activities commonly known under the description 'Research and Development' (R&D). Both terms 
are used interchangeably. 
10  European Commission, Factsheet Horizon 2020 Budget, retrieved on 13 April 2015, 
http://ec.europa.eu/research/horizon2020/pdf/press/fact_sheet_on_horizon2020_budget.pdf. 
11  European Commission, ‘Europe 2020 Targets: Research and Development’, Retrieved on 
16.04.2015: http://ec.europa.eu/europe2020/pdf/themes/16_rd_target_02.pdf. 
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summarized in Annex I, and their intertwinement is confusing and requires a certain level 
of expertise to see through. This observation is important insofar that complex 
administrative structures are deterrents for potential applicants. The complexity is such 
that specialized firms have emerged to give professional advice and help projects to 
maneuver through the European research funding jungle.12 
 
High-Quality Israeli Research 
Compared to the complex and hesitant research spending in the EU, Israel falls 
clearly out of range. A comparison of R&I expenditure shows that research plays a far 
more important role in Israel than it does in any MSEU.13 Its performance in research is 
impressive and far above the European average for a majority of indicators.14 Israel is 
rightly considered being part of the European ‘Innovation Leaders’,15 with a quality of 
research equal to those of the most advanced EU Member States.16 This makes Israel a 
highly reliable and valuable partner for Europe in the field of R&I policies.17  
Israel's R&I spending amounts 4,2 % of GDP, double the EU average 18 and 
characterized by a very knowledge-intensive economy which carries most of the research 
expenditures of the country.19 Expenditures of the public sector account only for about 
24% of total R&I spending, leaving the major share of investments in the hands of the 
private sector.20 This is accompanied by an impressive amount of business researchers, 
four times superior to the European average (14.8 for Israel, compared to 3.4 in the EU for 
2009)21.Nonetheless, a certain stagnation in Israel's R&I activity can be noticed in the past 
12 Interview with Stéphanie Horel, Bruges, 6 March 2015.  
13  OECD, 2014 edition of Research and Development Statistics, retrieved on 16.04.2015: 
http://www.oecd.org/innovation/inno/researchanddevelopmentstatisticsrds.htm. 
14 European Commission, ‘Research and Innovation Performance in the EU, Innovation Union 
Progress at Country Level’, Directorate General for Research and Innovation, European Union, 2014. 
p. 307. 
15 European Commission, ‘Research and Innovation Performance in Israel, Country Profile 2013’, 
Directorate General for Research and Innovation, European Union 2013, p. 3. 
16 Interview with an EU-Official, Brussels, 1 April 2015.  
17 Ibidem. 
18 European Commission, ‘Research and Innovation Performance in Israel, Country Profile 2013’, op. 
cit. 
19 Ibidem. 
20 ‘2014 Research an Innovation Report’, SGI -Sustainable Governance Indicator, Bertelsmann 
Stiftung 2014, retrieved on 14.04.2015: http://www.sgi-Network.org/docs/2014/thematic/SGI2014_ 
Research_and_Innovation.pdf. 
21 European Commission, ‘Research and Innovation Performance in Israel, Country Profile 2013’, 
Directorate General for Research and Innovation, European Union 2013, p. 1. 
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years, leading to a small reduction of investments and a general decline in scientific 
production.22 The latest EU R&I projections forecast a progressive decline of Israel's R&I 
expenditures.23  
Israel's R&I expenditure is an important base for the high quality scientific 
production it provides. The overall success and excellence of Israeli research is well 
demonstrated via its far above-average results in the European Research Council (ERC)24 
funding. The Israeli success rates in the awarding of funding outperform those of all 
European Member States and are surpassed only by Switzerland.25 Among the top higher 
education institutions hosting the most ERC Grantees, Israel is in third position, after the 
UK and Switzerland.26 Following the vivid remark of an EU Official, “The ERC is to research 
what the Formula 1 is to motorsports. It’s only for the best of the best. And Israel is one of 
the best in the ERC”.27 
 
A successful cooperation 
The scientific cooperation between the EU and Israel goes back to 1996, when 
Israel – as the first non-European country – started to be associated via a specific 
agreement to the European Framework Programme.28 This research cooperation could 
build on the existing ‘Association Agreement’ signed in 1995, which succeeded a previous 
‘Cooperation Agreement’ signed in 1975 with the European Communities.29  
Over time, the implication of Israeli research activities in the European Framework 
Programme augmented constantly. Under FP7 (2007-13) Israeli public and private 
institutions were associated in over 2000 common projects. 30  Israeli universities 
22 Ibidem. 
23 European Commission, ‘Research and Innovation Performance in the EU, Innovation Union 
Progress at Country Level’, op. cit. 
24 With the aim to ‘stimulate scientific excellence’ the ERC funding serves as useful indicator for the 
level of Excellency a country is able to reach in Science.  
25 European Research Council (ERC), ‘ERC and Israel – FP7 Achievements and H2020 Results’, 
March 2015, Unpublished (Internal) Document, p. 19. 
26 Ibidem. 
27 Interview with an EU-Official, European Research Council Executive Agency, Brussels, 1 April 
2015.   
28 European External Action Service, Scientific Cooperation between the EU and Israel, The 
Delegation of the European Union to Israel, retrieved on 14.04.2015: http://eeas.europa.eu/ 
delegations/israel/eu_israel/scientific_cooperation/index_en.htm. 
29 European External Action Service, Agreements between EU and Israel, Retrieved on 16.04.2015: 
http://eeas.europa.eu/delegations/israel/eu_israel/political_relations/agreements/index_en.htm. 
30 European Commission, Press Release-EU,Israel sign Horizon 2020 association agreement’, June 
2014, retrieved on 14.04.2015: http://europa.eu/rapid/press-release_IP-14-633_en.htm. 
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cooperated on 1.330 research projects, receiving a total of € 574 bn while Israeli industry 
participated in 464 projects with an estimated value of 2.1 bn.31 All in all, the Israeli return 
on investment in FP7 amounted to a considerable 60%.32 These numbers demonstrate the 
remarkable efficiency Israel reached in its research cooperation today. “The European R&D 
Framework Programmes have granted Israel a position of excellence, which we would not 
have attained in any other way” admits Prof. Ruth Arnon, President of the Israel Academy 
of Sciences and Humanities.33 The research cooperation is a chance for both sides, 
allowing Israel on one side to get access to European networks and funds, and for Europe 
on the other side to benefit from the excellent science of Israel.34 
  
2.  Lobbying European Research Policy – A Model 
The research policy of the European Union is defined by the European Research 
Framework Programme (FP) and implemented by the European Commission. The FP is a 
legislative act like any other, with the difference of being limited to a determined time 
frame. The FP Regulation is adopted via the Ordinary Legislative Procedure (OLP), which 
provides that the European Parliament and the Council approve jointly a proposal 
developed by the European Commission. Even though the repartition of roles appears 
equally distributed at a first glance, the Commission, and more precisely its Directorate 
General for Research and Innovation (DG RTD), plays a predominant role.35 Under the 
direction of its own Commissioner responsible for Research, DG RTD represents one of the 
biggest Directorate Generals (DGs) in the Commission, employing over 1000 Staff.36 It 
resembles a ‘European Research Ministry’,37 equipped with strong powers in shaping 
research policy. The legislation it prepares in view of each new FP can be described as a 
‘legislative package’ including several distinct legislative acts each covering specific fields 
of EU research policy. Today, the central piece of legislation consists of the H2020 
Regulation, establishing the 8th Research Framework Programme ‘Horizon 2020’. Next to 
31 ISERD, ‘Horizon 2020 – The European R&D Programme Takes Off’, 2014, retrieved on 14.04.2015: 
http://www.iserd.org.il/_Uploads/dbsAttachedFiles/ISERD_EN.pdf., p. 5. 
32 Ibidem. 
33 ISERD, ‘Horizon 2020 – The European R&D Programme Takes Off’, op. cit, p. 12. 
34 Interview with Hans-Olaf Henkel, European Parliament, Brussels, 15 April 2015. 
35 J. Stamm, ‘Towards new Horizons in Research Policy – The Changing Role of the Directorate-
General for Research (and Innovation)’, Student Paper Series, Hertie School of Governance, 2013, p. 
17. 
36 Ibidem. 
37 Ibidem.  
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the H2020 Regulation, a separate regulation defines the ‘Rules of participation’38 for 
participating actors and applicants, and a Council Decision on a ‘Specific Programme’39 
determines the objectives and rules to be followed during the implementation of H2020.40 
In its redaction phase, the Commission relies – like in most of its policies – more and 
more on public consultations.41 This enables interest groups to express their opinions and 
views, preferences and priorities via pre-defined procedures and questionnaires. 
Numerous consultations were held in preparation for H2020 and were of ‘enormous help’42 
to DG RTD in its redaction of the H2020 Regulation proposals.  
Once the FP adopted with its general objectives, the more specific implementation 
of H2020 is required. This is done in two steps:  
- First, via a nebulous triennial ‘Strategic Programme’43 in which the Commission (DG 
RTD) sets the priorities for its policy;  
- Second, via a biannual ‘Work Programme’44 inspired by the priorities set up in the 
‘Strategic Programme’. It defines the concrete objectives of the research policy for 
a bi-annual time period as well as the nature and size of specific funding calls. 
As defined in the ‘Specific Programme’, these ‘Work Programmes’ play a decisive 
role in European research policy.45 The adoption of the Work Programmes follows the 
38 Official Journal of the European Union, Regulation (EU) No 1290/2013 of the European 
Parliament and of the Council of 11 December 2013 laying down the rules for participation and 
dissemination in "Horizon 2020 - the Framework Programme for Research and Innovation (2014-
2020)" and repealing Regulation (EC) No 1906/2006. 
39 Official Journal of the European Union, Council Decision of 3 December 2013 establishing the 
specific programme implementing Horizon 2020 - the Framework Programme for Research and 
Innovation (2014-2020) and repealing Decisions 2006/971/EC, 2006/972/EC, 2006/973/EC, 
2006/974/EC and 2006/975/EC. 
40 For simplification, the total of legislative acts related to H2020 will be referred to in future under 
the term ‘H2020 legislative package’. 
41 See the list of closed consultation, in: European Commission, DG Research and Innovation, 
Consultations, retrieved on 28.04.2015: http://ec.europa.eu/research/consultations/list_ 
en.cfm#open. 
42 A Member of Staff in the Office of the Director-General for Research and Innovation: quoted in J. 
Stamm, op. cit., p. 19. 
43 The ‘Strategic-Programme’ (SP) was introduced under H2020. It’s a recent tool that needs to find 
its place in the system. It is nebulous insofar that it is not mentioned in the H2020 Legislation 
package and that information on that topic is simply inexistent on the Commissions Website. The 
SP defines 12 Areas of High Growth, designs Key Enabling Technologies (KETs) and launches 
Public-Partner Partnerships (PPPs).  
44“ 'Work programme' means the document adopted by the Commission for the implementation of 
H2020 in accordance with  Article 5 of Council Decision 2013/743/EU of 3 December 2013 (2)”, in: 
Official Journal of the European Union, Regulation (EU) No 1290/2013, op. cit. 
45 Interview with an EU-Official, Council of the European Union, Brussels, 1 April  2015. 
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‘Examination Procedure’ for implementing acts. 46 Similar to the drafting process of 
legislative acts, the Commission bases his work on extensive consultation.47 Compared to 
FP7, these consultations are more structured under H2020 via the collaboration of 
internal-working groups and cooperation between the relevant DGs. 48  Further, the 
Commission can rely on the advice of the ‘Programme Committee’, giving Member States 
a voice in the process. In its consultation with external stakeholders, the Commission 
consults on one hand a specific and formally established ‘Advisory Group’, and on the 
other hand  will also rely upon the less-formal input of the ‘European Technology 
Platforms’.49 In its implementing task, the Commission is supported by three distinct 
actors listed below. Due to a specific status and their independence from the Commission, 
they are entitled to adopt their own individual ‘Work Programmes’ following slightly 
different procedures. 
1. Joint Research Centre (JRC) is the in-house Sciences Service of the Commission 
and “contribute[s] to the general objective and priorities of Horizon 2020 by 
providing scientific and technical support to Union policies”.50 The JRC gives its 
opinion on the ‘Work Programme’ of the European Commission. Its own Work 
Programme is prepared by the Board of Governors of the JRC. 
2. The European Research Council (ERC) was set up by the Commission in order to 
implement the actions related to the ‘excellence Science’ Objective of H2020.51 
The ‘Scientific Council’ of the ERC establishes its overall strategy and its ‘Work 
programme’. This work programme is then adopted by the Commission, following 
the procedure for implementing Acts.52 This makes the ERC less independent from 
the Commission.   
3. The European Institute of Innovation and Technology (EIT) aims at enhancing 
Europe’s capacity to innovate. Its Governing Board provides strategic guidance 
46The procedure for ‘Implementing Acts’ is commonly referred to under the term ‘Comitology’. The 
delegation of implementing powers must be provided in the legislative acts, see: Official Journal of 
the European Union, Council Decision of 3 December 2013 establishing the specific programme 
implementing Horizon 2020, op. cit., Art. 5.  
47 European Commission, ‘Horizon 2020 Work Programme 2014-2015, table of Contents and General 
Introduction’, European Commission Decision C (2014)4995 of 22 July 2014. 
48 Interview with an EU-Official, Brussels, 1 April 2015.  
49 Interview with an EU-Official, Council of the European Union, Brussels, 1 April, 2015. 
50 Official Journal of the European Union, Council Decision of 3 December 2013, op. cit., Part VI. 
51 Ibidem, Art. 6. 
52 Ibidem. 
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and develops the triennial ‘Work Programme’.53 It is associated with H2020 but is 
distinct in the sense that its priorities are defined in a ‘Specific Innovation Agenda’ 
(SIA).54 The Work Programme shall be submitted to the EP, the Commission, the 
Council and the Economic and Social Committee for Information.55 
Once the programmes are defined, the concrete implementation needs to be made. 
In the last years, DG RTD has outsourced important domains of its activity to specialized 
agencies, namely the European Research Council Executive Agency (ERCEA) in charge of 
‘Excellent Science’ and the Research Executive Agency (REA).56 This outsourcing reflects 
a professionalization and bureaucratization of European research policy implementation 
while increasing the political leadership of DG RTD.57 Having the legal status of ‘Executive 
Agencies’,58 they are set up by the Commission for a determinate period of time and are in 
charge of the concrete implementation of the objectives and projects defined in the work 
programmes, starting from the selection of proposals to the final evaluation and 
disbursement of funds. From the point of view of interest representation theories, 
European research policy can be described as being somehow ‘sui generis’, since it is not 
limited to the pure elaboration of legislation but also largely involves further evaluation, 
adjustment and implementation measures. It involves an exceptionally high number of 
actors and procedures. Interest representation activity in EU research policy has not been 
adequately considered by academics so far. Relying on the descriptions above and 
inspired by existing models on European lobbying59 three relevant ‘phases of influence’ for 
interest representation at the EU level can be distinguished:  
 
53 Official Journal of the European Union, Decision No 1312/2013/EU Of The European Parliament 
and of The Council of 11 December 2013 on the Strategic Innovation Agenda of the European 
Institute of Innovation and Technology (EIT): the contribution of the EIT to a more innovative 
Europe, L 347/892. 
54 Adopted on Proposal of the Commission by the Council and the EP.  
55 Official Journal of the European Union, Regulation (EC) No 294/2008 Of The European Parliament 
and of The Council of 11 March 2008 establishing the European Institute of Innovation and 
Technology, L97/1, Art. 15. 
56 See Annex I giving an overview on research related EU-Institutions and bodies.  
57 J. Stamm, op. cit., p. 32. 
58 ‘Executive Agencies’ are different from EU Agencies, which are established for an indeterminate 
period of a time and under less strict supervision by the European Commission.  
59 Special attention was given to the ‘Post-Lisbon Model for Lobbying’ as developed by Daniel 
Guéguen. Developed for the best possible practical use by an experienced professional of European 
Lobbying, this model gives the most useful insights, see: D. Guéguen, Reshaping European Lobbying, 
Brussels, PACT European Affairs, Europolitics 2013.  
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Figure 1: Phases of European research policy development 
 
Framing-Phase 
Interest actors are presented every 5-7 years with the opportunity to reshape the 
broad political strategy during the negotiations of the Research Framework Programme 
(FP). At that stage, similar to other policy domains, important research priorities are 
defined by the classic institutions (Commission via DG RTD, EP, MSEU via the Council). At 
this first stage, general orientations for research are set for the years to come via a 
‘legislative package’. Hence, classic European lobby strategies and theories apply, offering 
a large range of options.60 Concretely, the role of lobbyists in research issues takes a very 
classic shape, consisting in “meeting with colleagues […], [to] jointly prepare input for 
amendments in parliament […] and submit joint papers and thoughts”.61 All these various 
specific interests are organized in numerous associations in Brussels, covering all 
imaginable research domains. Their role is important regarding the sensitization of 
decision makers to specific issues, since they raise awareness for the group they 
represent. Associations are the most classic tool in European interest representation. 
60 Guégen distinguishes between an ‘Upstream phase’ and the ‘Ordinary Legislative procedure’ 
itself. Both are merged in my model within the ‘Framing phase’. The reason herefore lays in the 
technicity of Research issues forcing the Commission to rely more than in any other domain on the 
input of experts and to elaborate its policy in close accordance with the scientific community. This 
raises the importance of pre-established channels of consultations taking place before and during 
the legislation. Distinguishing both phases becomes difficult. See: D.Guéguen, Reshaping European 
Lobbying, op. cit., p. 28. 
61 A National Research Lobbyist, quoted in: J. Stamm, op. cit., p. 18. 
Framing-Phase 
 About: H2020 Legislative Package 
Actors: Commission, EP, Council 
Shaping-Phase 
About: Strategic-/ Work Programme 
Actors: DG RTD, Programme 
Committee, Advisory Groups 
Implementing-Phase 
About: Funds/Projects 
Actors: DG RTD/Agencies 
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Another important and helpful tool of interest representation in the field of research 
emerged more recently in form of ‘European Technology Platforms’ (ETP).62 Established in 
2003, ETPs are “industry-led stakeholder forums approved by the European Commission 
as key actors in driving innovation, knowledge transfer and European competitiveness”.63 
ETPs are self-funded and self-organized, but require a formal recognition from the 
commission. Via the conclusion of ‘Strategic Research Agendas’ listing the most 
important aspects to be considered in their specific research field, ETPs contribute to the 
elaboration of agendas, roadmaps, networks and partnerships. Their semi-formal 
character differs from traditional ‘Association’ structures, making these platforms an 
unusual tool of European interest representation. For the period covered by H2020, the 
European Commission recognized in total 38 ETPs in domains ranging from ‘Aviation 
Research’ to ‘Zero Emissions’. 64  ETPs are playing a key role in the Commissions 
consultations and can be identified as a further considerable input opportunity for interest 
groups in research related topics. 
 
Shaping-Phase 
The name chosen for this second phase may be surprising at a first glance, since 
the acts it refers to are misleadingly called ‘Implementing Acts’. To judge from their 
important role in fixing research priorities and setting the calls for funding, the ‘Work 
Programmes’ (and their preceding ‘Strategic Programmes’) can be considered as the real 
shapers of European research policy. Far less visible, but estimated to produce impressive 
3/4 of the total regulatory activity of the Union,65 the infamous comitology procedures 
generating these ‘implemented acts’ are largely criticized for being a real ‘hidden power’.66 
Technicality and opacity makes the implementing acts a particular challenge for interest 
actors as well as for experienced members of the MSEU and the EU Institutions.67 It 
62 Briefly mentioned by J. Greenwood in one phrase, ETPs have not been subject to further research 
yet. See: Greenwood, op. cit., p. 91. 
63 European Union, European Technology Platforms, retrieved on 28.04.2015: http://ec.europa.eu/ 
research/innovation-union/index_en.cfm?pg=etp. 
64  European Commission, ‘Commission Staff Working Document - Strategy for European 
Technology Platforms: ETP 2020’, SWD(2013) 272 final, Brussels, 12.7.2013. 
65 96% following the estimations of Daniel Guéguen, See: D. Guéguen, Comitology –Hijacking 
European Power?, Brussels, PACT European Affairs, Europolitics 2014, p. 27. 
66 Term used in: G.J. Brandsma, Controlling Comitology, Accountability in a Multi-Level System, 
Basingstoke, Palgrave Macmillan 2013. 
67 D. Guéguen, Comitology – Hyjacking European Power?, op. cit., p. 47. 
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further reinforces the role of the Commission, since it appears to be the European 
institution really dominating the comitology procedures.68 For any type of outside actor, 
Member State or association, the leveraging power on comitology-procedures is very 
limited. Following the advice of Daniel Guéguen, expert in comitology, the only action to be 
recommended for interest actors would consist in preventive actions at level of the 
relevant DG.69  
But sticking to that would not take into account the specificities linked to European 
research policy. Three leveraging channels specific to the ‘Work Programmes’-comitology 
can be retained:  
1. The ‘Programme Committee’ is a forum for all the states associated with H2020. It 
assists the Commission in the elaboration of the ‘Work programmes’ and approves 
them. 70 Meetings take place in different constellations 3-4 times a year, in 
accordance with the priorities set up under H2020. Members of the programme 
committee are delegates and experts from the national governments. This enables 
them to speak up in favor of national interests or the interests of specific national 
actors. 
2. The ‘Advisory Groups’ are independent experts assisting the Commission in the 
‘preparation, implementation or evaluation of programmes and design of policies’71 
in the field of research. The selection of experts is made by the Commission 
following the strict rules applying for all Commission expert groups.72 These 
provisions are set up quite effectively to prevent the influencing of experts via 
external interest groups. Nonetheless, the impact of an expert’s nationality on 
decisions and advice can never be completely excluded.73 Moreover, and despite 
the prohibition to reveal internal information to third actors, experts’ participation in 
the ‘Advisory Groups’ provides useful insights which can be of benefit in other 
fields. 18 ‘Advisory Groups’ are set up under H2020.  
68 Ibidem.  
69 D. Guéguen, Reshaping European Lobbying, op. cit., p. 73. 
70 Official Journal of the European Union, Council Decision of December 3, 2013, op. cit., Art. 10. 
71  European Commission, Horizon 2020 Expert groups, retrieved on 30.04.2015: http:// 
ec.europa.eu/programmes/horizon2020/en/experts. 
72 European Commission DG RTD, Mandate of the Horizon 2020 Advisory Group for International 
Cooperation, retrieved on 30.04.2015: http://ec.europa.eu/transparency/regexpert/index.cfm?do= 
groupDetail.groupDetailDoc&id=12974&no=1. 
73 Interview with an EU-Official, Brussels, 1 April 2015.  
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3. The ‘European Technology Platforms’, already mentioned for their role in the 
drafting of the H2020 legislation package, plays also a role in the strategic-
programming of the ‘work programmes’. But unlike its participation in the H2020 
Package, its role is here purely informal. The helpful contribution of ETPs in the 
definition of ‘strategic research agendas’ was mentioned in passing by DG RTD in 
its last working document on ETPs.74 This absence of procedures leaves a grey 
zone which offers a clear opportunity for interest groups to influence the ‘Work 
Programmes’ via the ETPs.  
For the ‘Work Programmes’ adopted by the JRC, the ERC and the EIT interest 
groups should concentrate respectively on the Board of Governors, the Scientific Council 
and the Governing Board in charge of its redaction.   
Despite the deterrent and opaque ‘comitology’ procedures, the ‘shaping phase’ 
offers some relevant channels of influence. The bi-annual rhythm for the ‘work programme’ 
redaction increases its importance since it becomes a cycle of permanent consultation 
and involvement opportunity. 
 
Implementing Phase 
The last phase consists in the specific policy implementation structure. What may 
appear a simple technical issue represents a ‘big concern’75 for research actors. Via yearly 
renewed calls for funding, research interests have to deal with important and ongoing 
implementation and administration issues regarding the concrete application and funding 
requirements. Addressing this ‘bureaucratic obstacle’ is crucial for the good transmission 
of H2020 to the actors it targets. The activity is dominated by professional bodies in 
charge of the implementation of a given legislation. This complicates the approach for 
interest groups, since “no space for the interference of interest actors”76 is foreseen nor 
desired at the level of implementation. Proposals are first checked for their eligibility by 
the competent department and then assessed in detail by at least three independent 
experts.77 The evaluation criteria are pre-defined according to the priorities of H2020 and 
74 European Commission, ‘Commission Staff Working Document  Strategy for European Technology 
Platforms: ETP 2020’, op. cit., p. 2. 
75 A National Research Lobbyist, quoted in: J. Stamm, op. cit., p.18. 
76 Interview with an EU-Official, Brussels, 1 April, 2015. 
77 Interview with an EU-Official, European Research Council Executive Agency, 1 April 2015. 
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the respective ‘work programme’.78 The assessing expert evaluators are selected from a 
Commission database open to everyone with verifiable expertise.79 No doubt is allowed 
that the evaluation is entirely impartial.80 Further, the responsible official (project officer) 
of the Agency/Commission cannot influence the outcome of the evaluation,81 making 
direct lobbying obsolete. Generally, active lobbying in favor of a project is by no means 
advised. The effect would rather be counter-productive, since “A project that needs to 
lobby for itself with other means than its scientific excellence nullifies its credibility right 
from the start”.82Nonetheless, their administrative work in the disbursement of funding, 
selection and evaluation of projects and proposals, application and evaluation of criteria, 
etc. remains important for any research-related actor willing to apply for funding. This 
uncertainty and complexity regarding concrete practical aspects managed at 
implementation level discloses a 'gap' between the H2020 package and its ‘work 
programme’ on one hand and the effective implementation on the other hand. This 
identified 'gap' is to be borne in mind, since it is of crucial importance to later understand 
the activity of Israel in the ‘implementing phase’ of European research policy. The 
Commission, aware of this 'gap', has established a system of National Contact Points 
(NCPs) in order to counter the problem. The definition of their task is very clear:  
Spreading awareness, giving specialist advice, and providing on-the-ground 
guidance, they [NCPs] will ensure that the new programme [H2020] becomes 
known and readily accessible to all potential applicants.83  
Nonetheless, the Commission sets only low minimum requirements and states in 
its instructions that “National Contact Points will be established, operated and financed 
under the responsibility of the Member States and countries associated to the 
78 Ibidem. 
79  The registration can be done online, see: European Commission, Research & Innovation 
Participants Portal, retrieved on 30.04.2015: http://ec.europa.eu/research/participants/portal/ 
desktop/en/experts/index.html. 
80 Interview with Stephanie Horel, Expert in EU-Funding Management, Bruges, 6 March 2015. Every 
actor consulted on the subject, being internal or external to the institutions, asserted me the 
objectivity and professionalism of the evaluation procedures. 
81 Ibidem.  
82 Interview with an EU-Official, European Research Council Executive Agency, Brussels, 1 April 
2015. 
83 European Commission - DG RTD - Unit A3, Minimum Standards and Guiding principles for setting 
up systems of National Contact Points under Horizon 2020, retrieved on 1.05.2015: 
http://ec.europa.eu/research/participants/data/support/20131125_NCP%20Minimum%20standard
s.pdf. 
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programme”.84 Each country keeps an important margin of appreciation in the way it 
organizes its NCP, which means that “The NCP systems can vary from one country to 
another” and thus the “level of services offered may differ from country to country”.85 This 
leads sometimes to ‘important differences’ between the NCPs. 86  Considered as 
particularly problematic, the Commission recently launched the initiative of a 
‘Transnational Network of National Contact Points’ aiming at “helping less experienced 
entities [NCPs] in low performing Member States”.87  
Based on the observations thus far, the following ‘European Research Lobbying 
Model’ can be deduced. The red arrows are listing the identified ‘channels of influence’ at 
each phase. 
Figure 2: European Research Lobbying Model 
 
 
84 Ibidem. 
85 European Commission., Research and Innovation participant Portal – National Contact Points, 
retrieved on 04.05.2015: http://ec.europa.eu/research/participants/portal4/desktop/en/support/ 
national_contact_points.html#c,contact=country/sbg/Israel/1/1/0&function_details..function_abbr
/sbg/null/1/1/0&+country/desc.  
86 Interview with an EU-Official, Brussels, 1 April 2015.  
87 European Commission, Horizon 2020 – Work Programme 2014-2015, European Commission 
Decision C (2015)2453 of 17 April 2015, retrieved on 5.05.2015: http://ec.europa.eu/ 
research/participants/data/ref/h2020/wp/2014_2015/main/h2020-wp1415-sewp_en.pdf. 
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3. On the trail of Israeli research interest  
The reference to ‘classic’ lobbying actors embraces associations in their broadest 
interpretation (including regular forums, organized networks, etc.). Their role can be 
retained as the most relevant here88. At first glance, Israel has a very visible and powerful 
network in Brussels in the form of influential organizations. According to various 
sources,89 the most important organizations include:  
- European Jewish Congress (EJC) 
- B’Nai B’Rith Europe 
- European Coalition for Israel (ECI), 
- Israel Allies Foundation (IAF) 
- The Transatlantic Institute (TAI) 
- European Friends of Israel (EFI) 
A leading role is played by the ‘European Friends of Israel’ (EFI), aiming at 
becoming for Europe what the ‘American-Israel Public Affairs Committee’ (AIPAC) is to the 
United States.90 Their strategy is to concentrate their activity on focusing on the European 
decision makers while intentionally “ignoring the EU’s complex decision-making 
structure”.91 Their overall presence and the numerous events they organize as well as their 
members and forums give them powerful tools to intervene in public debates. 
Nonetheless, having a look at their agenda, their focus lays with very general issues of  EU-
Israeli relation, such as foreign policy, Jewish culture, or the Israeli-Palestinian conflict.  
They contribute to create a general positive mood in favor of Israeli concerns, but 
they have no impact or expertise at all in a domain as technical as research. “They don’t 
matter on research issues” explains Mr. Gil Mor from the Israeli Mission to the EU,92 an 
assessment shared by David Cronin.93 On the contrary, their impact on Israel research 
88 J. Greenwood, op. cit., p. 14. 
89 Information received during Interviews, and; Corporate Europe Observatory (CEO), ‘Spin Doctors 
to the Autocrats: How European Firms whitewash repressive Regimes’, retrieved on 5.05.2015: 
http://corporateeurope.org/sites/default/files/201500303_spindoctors_lr.pdf. 
90 U.Yildiz, ‘The Influence of the European Friends of Israel on the Members of the European 
Parliament’, Alternative Turkish Journal for International Relations, Vol. 13, No. 4, Winter 2014, p. 2. 
91 Ibidem. 
92 Interview with Mr. Gil Mor, Mission of Israel to the EU, Minister-Counselor for Industry and Trade, 
Brussels, 1 April 2015.  
93 Interview with Mr. David Cronin, Brussels, 31 March 2015. Cronin is author of the critical Book: 
Europe-Israel: une alliance contre nature (op.cit) (Eng: Europe’s Alliance with Israel). 
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interests appeared to be rather negative, as shown by the escalation of accession 
negotiations of Israel to H2020. 
The disaster of Israel's Accession to H2020 
In 2012 it was self-evident that the effective cooperation between Israel and the EU 
in research issues would continue. The formal steps to follow were set via a formal 
agreement on the association of Israel to H2020 for Research and Innovation (2014-
2020).94 Following the requirements defined in the FP Regulation, the modalities of 
associations needed to be renegotiated for each new FP individually.95 A legal detail with 
significant impact was that the association agreement was not signed under the form of a 
new international agreement like it has been the case for the FP7,96 but as an additional 
protocol to the existing Euro-Mediterranean Association Agreement (AA) between Israel 
and the European Communities (EC) signed in 1995.97 This had a double consequence: on 
one hand, it isolated the MSEU and the EP, providing the Commission and its External 
Action Service with a unique lead in the negotiation process. This shift of competences, 
especially with regards to the complications that followed, led to some inter-institutional 
irritations.98 On the other hand, it allowed the EU negotiators to increase their conditions, 
demanding that “this agreement shall not apply to the geographic areas that came under 
the administration of Israel after 5 June 1967”. 99  This phrase, introduced by the 
Commission in “accordance with existing EU policy”,100 had the effect of preventing any 
further financial transfers to bodies in the West bank, the Gaza Strip and the Golan 
Heights. For Israel, it was perceived as unacceptable and outrageous at the highest level, 
94 European External Action Service, Scientific Cooperation between the EU and Israel, op. cit. 
95 Official Journal of the European Union, Regulation (EU) No 1291/2013 of The European 
Parliament and of The Council of 11 December 2013 establishing Horizon 2020  the Framework 
Programme for Research and Innovation (2014-2020) and repealing Decision No 1982/2006/EC. 
96 Official Journal of the European Union, Agreement on scientific and technical cooperation 
between the European Community and the State of Israel - Final Act - Joint Declaration, [OJ L 220 , 
25/08/2007 P. 0005 – 0021]. 
97  Official Journal of the European Union, Euro-Mediterranean Agreement establishing an 
association between the European Communities and their Member States, of the one part, and the 
State of Israel, of the other part [OJ L 147 of 21.6.2000]. 
98 Interview with an EU-Official, Council of the European Union, Brussels, 1 April 2015. 
99 ISERD, Agreement between the State of Israel and the European Union on the participation of 
Israel in the Union Programme “Horizon 2020 – The Framework Programme for Research and 
Innovation (2014-2020)”, retrieved on 16.04.2015: http://www.iserd.org.il/_Uploads/ 
dbsAttachedFiles/EU_Israel_sign_Horizon_2020_association_RD_agreement_en.pdf. 
100 Ibidem. 
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since Israel “will never accept any outside diktat about its borders”. 101  The Israeli 
administration let the opinion know that it is  
“not prepared to sign such an item in our contracts with the EU […] The result may 
be termination of our entire cooperation in the areas of the economy, science, 
culture, sports and academia”.102  
Media and politicians in Israel and Europe, with large support from the pro-Israel 
forums described above, started to take positions on the issue, making the administrative 
issue a matter of public debate.103 Faithful to their claim to influence the Israel-EU 
relationship, ‘European Friends of Israel’ activated its parliamentary network and sent an 
open letter to the High Representative Baroness Ashton, asking her to reconsider the 
conditions of the Association.104 The ‘Friends of Israel Initiative’ intervened via an open 
letter of 15 former ministers and prominent politicians repeating the same claim.105 The 
European Parliament (EP) issued another open letter expressing opposite opinions.106 It 
was followed by the public positioning of Palestinian NGOs107, European academics108 and 
Israeli intellectuals109, thus  preventing the subject from entering into a public political 
debate. According to an informed EU official, this politicization goes back to Israel, even 
calling upon US Secretary of State  John Kerry to exercise pressure on the MSEU110. 
101 Israel Prime Minister Benjamin Netanyahu, quoted in: R. Ahren, ‘EU, Israel headed for showdown 
over settlement rules’, Times Of Israel, 7.08.2013, retrieved on 19.04.2015: http:// 
www.timesofisrael.com/eu-israel-headed-for-showdown-over-settlement-rules/. 
102 A Senior Israeli Government Official quoted by: Barak Ravid, ‘Despite Israeli objections, EU 
officially publishes new settlement guidelines’, Haaretz, 19.07.13, retrieved on 19.04.2015: 
http://www.haaretz.com/news/diplomacy-defense/.premium-1.536812#Scene_1. 
103 To quote here for an example: M. Ostroff, Open-Letter to EU Foreign-Policy Chief Baroness 
Ashton, Jerusalem Post, 9.11.2013, retrieved on 19.04.2014: http://www.jpost.com/Experts/ 
Baroness-Ashton-please-explain-325848. 
104 European Friends of Israel, EFI released open letter about EU Guidelines, retrieved on 2.05.2015: 
http://www.efi-eu.org/index.php?option=com_k2&view=item&id=355:efi-released-an-open-letter-
about-the-eu-guidelines&Itemid=141.  
105  Friends of Israel Initiative Website, retrieved on 2.05.2015: http:// 
www.friendsofisraelinitiative.org/article.php?pagina=10&c=119. 
106  ECC Palestine Website, European Parliament Letter, retrieved on 2.05.2015: 
http://www.eccpalestine.org/wp-content/uploads/2013/09/Letter-signed-by-51-MEPs.pdf. 
107  BDS Movement Freedom and Justice Website, retrieved on 2.05.2015: 
http://www.bdsmovement.net/2013/eu-must-not-bow-to-us-pressure-to-disregard-human-rights-
11315. 
108  BDS Movement Freedom and Justice Website, retrieved on 2.05.2015: 
http://www.bdsmovement.net/2013/500-academics-eu-letter-11329. 
109  BDS Movement Freedom and Justice Website, retrieved on 2.05.2015: 
http://www.bdsmovement.net/2013/600-israeli-intellectuals-send-letter-support-eu-settlement-
guidelines-11334 
110 Interview with an EU-Official, Brussels, 13 March 2015. 
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Regular and intended leaking of the status of negotiations to the Israeli press and turmoil 
in the EP led to ‘abnormal negotiations’.111 What could have been a simple formality 
became a politicized arm wrestling match between both delegations. 
Unimpressed and to a certain extent encouraged by this medial turmoil,112 the 
Commission, via its EEAS, retained its factual argumentation, stating that it was only 
acting in accordance with international law and enforcing existing policies.113 At the same 
time, Israeli scientists and politicians underlined unanimously the crucial importance of 
European Research Networks and funding for Israel. “The Israeli investment in Horizon 
2020 is significant,” explained Prof. Yoav Henis, Manager for R&D at Tel Aviv University 
“The return we received on our investment in FP7 was of the highest importance.”114 
Interviewed on the impact of the dispute between Israel and the EU, Nobel Prize recipient 
in Chemistry, Professor Dan Shechtman, stated that “our partnership with the European 
Union in the present and the future is vital to the sciences in Israel. […] As a scientist I say 
to the government of Israel: We need this agreement and you should make the best effort 
to sign it. 115  Prof. Ruth Arnon, President of the Israel Academy of Sciences and 
Humanities, communicated the serious concerns of the scientific community in her talks 
with Prime Minister Netanyahu, explaining that the exclusion of Israel from H2020 would 
lead to “irreversible damage to Israeli sciences in particular and to the state in general”.116 
She openly urged the government “in the name of the Israeli scientific community” that 
this agreement “must be signed”.117  
Finally, the agreement was signed on June 8, 2014 providing Israeli researchers, 
universities and companies with full access to the Horizon 2020 Programme.118 The 
111 Ibidem. 
112 Ibidem. 
113 European External Action Service, Formal Response Letter of Leone Gabrielli, Head of Division to 
Mr. Maurice Ostroff, Journalist at the Jerusalem Post, 17.12.2013, retrieved on 18.04.2015: 
http://www.jpost.com/Blogs/2nd-Thoughts/Response-by-Baroness-Ashton-to-letter-re-Horizon-
2020-364136. 
114 Ibidem. 
115 A. Somfalvi, ‘Report: Israel, EU reach understanding regarding Horizon 2020’, YnetNews, 
November 2013, retrieved on 14.04.2015: http://www.ynetnews.com/articles/0,7340,L-
4458364,00.html. 
116 Prof. Ruth Arnon, quoted in: J. Siegel-Itzkovich, ‘Israel Academy of Sciences President: Israel 
must sign Horizon 2020’, Jerusalem Post, 21.10.2013, retrieved on 19.04.2015: 
http://www.jpost.com/Enviro-Tech/Israel-Academy-of-Sciences-president-Government-must-sign-
Horizon-2020-329289. 
117 Ibidem.  
118 European Commission, ‚Press Release-EU, Israel sign Horizon 2020 association agreement’, op. 
cit.  
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provisions of Article 6-1 remained, rendering ineligible a marginal number of projects 
located beyond the borders of 1967. The visible pro-Israel networks failed to rightly 
address the issue. Their impact and pressure rather strengthened the determination of the 
Commission not to soften its position, as confided an EU-Official.119  
Research Associations 
Compared to the active representation on political level, it is striking, that Israel is 
only moderately present in specific research related associations. Out of the most 
important Israeli research beneficiaries listed below, none  has its own representation in 
Brussels.  
 
Table 1: The most Important beneficiaries of FP7 in Israel 
Institution EU Funds Received (2013)120 in Mio. € 
The Hebrew University of Jerusalem 100.5 
Tel Aviv University 89.3 
Weizmann Institute 81.6 
Technion – Israel Institute for Technology 46.1 
Israel Aerospace Industries LTD. 28.9 
Ben-Gurion University of the Negev 26.8 
Bar-Ilan University 10.7 
University of Haifa 9.8 
IBM Israel – Sciences and Technology LTD. 6.8 
 
The only Israeli corporation registered on the European Transparency Register 
(ETR) is TEVA Pharmaceuticals Europe BV, with a declared annual budget of 
approximately €500,000.121 This small presence of Israeli research-intensive businesses or 
119 Interview with an EU-Official, Brussels, 13 March 2015. According to Guy Harpaz, the research 
cooperation with IL enables the EU to follow a ‘carrot and stick’ approach, meaning scientific 
cooperation in exchange for political concessions in the Israeli-Palestinian conflict, See: G. Harpaz, 
‘The European Union, The Mediterranean and the European Neighbourhood Policy: An Israeli 
Perspective’, in: Guy Harpaz and Rachel Frid, "The Wider Europe Initiative", 9(1) International Trade 
Law and Regulation N-6-7(2004), p. 26. 
120 The Numbers come from the Financial Transparency System of the European Commission and 
take into account the last year available, see: http://ec.europa.eu/budget/fts/index_en.htm 
121 European Transparency Register, TEVA Pharmaceuticals Europe BV, retrieved on 14.04.2015, 
http://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=27116427434-
57. 
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universities is not really surprising, since the weight of corporations/institutions acting 
independently is limited because aggregated interests coming from associations are 
considered by European institutions as being more representative and balanced.122  
If not directly represented, the membership of Israel/Israeli-actors123 in specialized 
research association represents the second option for establishing a presence in Brussels. 
The analysis of relevant associations and networks in Brussels presents quite surprising 
results. A list of the most relevant research related associations in Europe is provided in 
Annex II. From 29 associations/networks selected for their relevance, Israel/Israeli-actors 
are only members in 10 of them.124 The absence of Israel/Israeli actors is clearly striking 
with regard to the most important associations in the domain of research. This is notably 
the case for the European Association of Research and Technology (EARTO) as well as for 
the overarching European Universities Association (EUA). This is also the case for those 
associations matching well with domains where Israel possesses high scientific expertise. 
No Israeli actor is a member of the European Federation of Pharmaceutical Industries and 
Associations (EFPIA), the Aero-Space and Defense Industries Association of Europe (ASD), 
the Association of European Research Establishments in Aeronautics (EREA) or the all-
powerful ‘Digital Europe’, despite its huge research activities in the pharmaceutical, 
aeronautic and nano-technological sectors. 
The weak participation of Israel/Israeli actors in these associations is surprising. 
The assumption of calculated Israeli ‘free riding’,125 meaning the calculated benefit from 
the efforts of associations without contributing via membership, is unlikely, since it 
deprives Israel of the possibility to shape the association’s policy and thus the message to 
transmit to institutions via consultations or other means. Moreover, this excludes Israel 
from the central added value these associations offer, their networks. A further reason for 
the weak Israeli presence in associations might be the role of officially recognized 
European Technology Platforms (ETPs) likely to take over the role and influence of 
associations. Since many associations are themselves members in ETPs, this can be 
122 J. Greenwood, op. cit., p. 66. 
123 The term 'Israeli-actors' refers to all entities from Israel not representing the State of Israel 
(businesses, universities, foundations etc.) 
124 See Figure IV: ‘Membership of Israel/Israeli-Actors in Relevant Associations’. 
125 B. Wessels, ‘Interest groups and political representation in Europe’, 1997, Wissenschaftszentrum 
Berlin, retrieved on 21.04.2015: http://www.wzb.eu/~wessels/Downloads/ECPR97-3.pdf. p. 7. 
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questioned and would require further research. The implication of Israel in ETPs will be 
considered in the next section.126  
Shaping Research Policy - Israel acting from within 
As indicated above, the ‘work programmes’127 are the real drivers of European 
research policy. Via its association with H2020, Israel has its place in formal governance 
structures, enabling it to officially speak up and intervene formally on the orientation of 
H2020. Israel is granted an Observer Status in the ‘Programme Committees’ (PC) 
consulted by DG RTD for the redaction of the ‘Work Programmes’.128 With the difference 
that voting is to be made “without the presence of the representatives of Israel”,129 the 
general participation of Israel “shall take the same form  […] as that applicable to 
representatives from Member States of the European Union”.130 Concretely, this means 
that Israel has a full insight in the positions and negotiations related to the shaping of 
H2020. Even if it has no right to vote, Israel is allowed to speak and to call attention to the 
concerns and interest of Israel in front of all MSEU. The presence of Israel in the 
“Programme committee is important and very beneficial for them”, explains an official 
from DG RTD, "they take the meetings very seriously, sending “high level experts from the 
Israeli ministries”.131 A Council official confided that Israel “uses its right to speak 
extensively”.132 
The cooperation of Israel with the Joint Research Centre (JRC) is of a slightly 
different nature, since the JRC is not an administrative entity but a real scientific research 
body. Its cooperation with Israel is thus based on a series of distinct agreements on 
specific scientific issues.133 Nonetheless, its role as scientific advisor to the Commission 
makes it an important actor. Similar to its position within the ‘Programme Committee’ (PC) 
126 ETPs are a channel of influence as well at the ‘Framing-‘ as at the ‘Shaping-Phase. The choice of 
analyzing ETPs under the second phase lays in the special nature of ETPs as described under 
Chapter III (half official consultation bodies involved within rather that outside of the system)and 
on the will to emphasize their difference from other Associations.  
127 Reminder: the main ‘Work Programme’ is elaborated by DG RTD, while the ERC, EIT and JRC have 
each a distinct ‘Work programme’ elaborated by their own governing structures.  
128 Agreement between the State of Israel and the European Union on the participation of Israel in 
the Union Programme “Horizon 2020 – The Framework Programme for Research and Innovation 
(2014-2020)”, op. cit., Art. 5. 
129 Ibidem, The Agreement precise that IL shall be informed of the results afterwards.  
130 Ibidem.  
131 Interview with an EU-Official, DG RTD, Brussels, 31 March 2015. 
132 Interview with an EU-Official, Council of the European Union, Brussels, 1 April 2015. 
133  European External Action Service EEAS, Scientific Cooperation, retrieved on 3.05.2015: 
http://eeas.europa.eu/delegations/israel/eu_israel/scientific_cooperation/index_en.htm. 
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to H2020, Israel has an observer status in the Board of Governors of the JRC that 
elaborates the ‘Work Programme’ of the JRC.134 Like with the PC, Israel can participate like 
any other MSEU, again with the possibility to address its concerns at highest level.  
Different from the board of governors of the JRC and the ‘Programme Committee’, 
nationality plays only a marginal role in the European Research Council (ERC). Its 
‘Scientific Council’ in charge of the redaction of the ‘work programme’ is composed of 
“scientists, engineers and scholars of the highest repute and appropriate expertise”.135 
According to a high official to the ERC, they are  
Appointed by the Commission, following an independent and transparent 
procedure. The only thing that matters in the ERC is scientific excellence. 
We don’t give any attention to nationality to a point that I couldn’t even tell 
you which nationalities are represented in the Scientific Council today.136 
At the moment, Israel is not represented in the Scientific Council. Israel’s presence 
was guaranteed until the end of last year via Prof. Daniel Dolev from the Hebrew University 
of Jerusalem, whose four years term ended in 2014. Since the ‘Work Programme’ of the 
ERC needs to be further adopted by the Commission via the procedure for implemented 
acts, the role of the Scientific Council lies more in its position to provide credibility and 
expertise than to proceed to a real shaping of research policy. Similar to the ERC, the 
governing board of the European Institute of Technology (EIT) is composed of “high-level 
members experienced in higher education, research, innovation and business”.137 The EIT 
is largely independent from all MSEU. No member of the board has been from Israel yet.138  
What can be observed above is that Israel has its place in the system and can 
shape it from within. “We [Israel] are members in internal committees. In this sense, we are 
Europeans, although we are not Europeans following the definition of the Council of 
134 ISERD, ‘Agreement between the State of Israel and the European Union on the participation of 
Israel in the Union Programme “Horizon 2020 – The Framework Programme for Research and 
Innovation (2014-2020)”, op. cit., Art. 6. 
135 Official Journal of the European Union, Council Decision of 3 December 2013, op. cit., Art. 7.  
136 Interview with an EU-Official, European Research Council Executive Agency (ERCEA), Brussels, 1 
April 2015.  
137 Official Journal of the European Union, Regulation (EC) No 294/2008, op. cit., Art. 4. 
138 It shall be indicated briefly, that Israel is also taking part in other concrete projects with the EU, 
where it also has its voice. Since the cooperation within these projects are arranged via separate 
agreements distinct from the PF Policy of the Union they are not of primary relevance here. To 
mention here the Israeli-EU Agreement regarding the European Space Agency (ESA) and the 
Observer Status of Israel in the European Research Area Committee (ERAC) providing Advice to the 
EU on matters regarding the European Research Area. 
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Europe” explains Marcel Shaton, Director General of the Israel-European R&D Directorate 
(ISERD).139 This place in the system is a significant ‘channel of influence’ for Israel. 
According to the observations above, this channel can be best used via the ‘Programming 
Committee’ for H2020 and the Board of Governors of the JRC . 
Advisory Groups 
As disclosed in Annex III, in 6 out of 18 of the ‘advisory groups’, an expert from 
Israel participates in the advisory procedures. This appears to be few at first glance, but 
taking into account that each group has on average only 10-15 experts and that not all 
MSEU are represented in the advisory groups, the presence of Israeli experts is rather 
satisfying. This is even more the case for a country being only associated to the FP. 
Compared to the other high-performing associated states of Switzerland (4 Experts) and 
Norway (3 Experts), Israel can consider itself well represented. At the same time, it is 
interesting to observe how the membership of experts in the groups fits with the scientific 
focus of Israeli research. Hence, the presence of experts in the advisory groups 
‘Nanotechnologies’ and ‘Secure Societies’ is not surprising. Nonetheless, the importance 
of these experts, who are selected for their scientific expertise only, should not be 
misunderstood. Certainly, their presence may have the positive effect of sensitizing the 
Commission and their scientific partners for issues of Israeli concern (if at all), but these 
experts are difficultly vectors of interests for Israel. Their presence can be relevant with 
regard to networking among researchers and to gain insights in the EU research policy 
domain.  
European Technology Platforms  
Unlike the Advisory Groups, the ETPs are recognized by the Commission but are 
organized independently. Their ‘Strategic Research Agenda’ provides useful advice to the 
COM, but it is also a channel of interest representation for its members.140 As disclosed in 
Annex IV, from the 38 ETPs (+2 Cross ETP Initiatives) recognized by the Commission for 
H2020,141 Israel/Israeli-actors could only be identified in 13 of them. Considering the 
139 ISERD YouTube-Channel, Marcel Shaton – Israel-France, i24, retrieved on 4.05.2015: 
https://www.youtube.com/watch?v=99x3kp2Mf88. The role of ISERD will be presented in the next 
sub-chapter.  
140 These are mostly Businesses, Research Institutes or other European Associations.  
141  European Commission, ‘Commission Staff Working Document - Strategy for European 
Technology Platforms: ETP 2020’, op. cit.  
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(intentional) broadness and openness of these associations, 13 is rather few.142 It can be 
observed that the presence of Israel in the ETPs is similarly low to the one it has in the 
relevant associations. The absence of Israel/Israeli actors in the ETPs ACARE and 
ARTEMIS is quite surprising, considering the important research focus of Israeli-science 
on aerospace technologies. A deliberate absence of the controversial Israel Aerospace 
Industries (IAI) from these platforms might make sense, but then it is surprising to find IAI 
as a member of the European Robotics Technology Platform. The analysis of ETPs and 
associations is interesting insofar that it shows a rather limited presence of Israel/Israeli 
actors in the visible Brussels research scene.  
Implementing Research Policy - it’s all about ISERD 
Israel adheres to the requirements of the Commission to establish National 
Contact Points (NCPs) for all states participating in H2020. Israel has a total of 12 NCPs. 
This is not much, considering the importance of research cooperation with Europe. In 
contrast, the associated H2020 members Switzerland and Norway have far more, with 
respectively 21 (CH) and impressive 42 (NO) NCPs.143 Leading European R&D countries 
like France and Germany can even have around 100 NCPs. Nonetheless, the number of 
NCPs communicated to the Commission does not give an indication about the network 
behind them, nor about their internal organization.  
The particularity of the Israeli NCPs is that their system is highly centralized, 
regrouping all NCPs under the roof of one organization: the Israel-Europe R&D Directorate 
(ISERD). This is not the case for all states (especially among the MSEU), where NCPs are 
often selected within relevant agencies, ministries or research institutions. By regrouping 
all Israeli NCPs within ISERD, the institution becomes the key player in the organization 
and cooperation of research between Israel and Europe.144 The European Commission 
formally refers to ISERD as “Israel’s official National Contact Point”.145 
142 More generally, some studies and analyses on the composition of ETPs (Type of Actors, 
Geographical distribution etc.) would be a subject of study providing useful insights. 
143 The NCPs can be retrieved on the Commissions Participant Portal, see: European Commission, 
Research and Innovation Participant Portal, NCPs, retrieved on 04.05.2015: http://ec.europa.eu/ 
research/participants/portal4/desktop/en/support/national_contact_points.html#c,contact=countr
y/. 
144 Other examples for states concentrating their NCPs in centralized structures are: ‘Tubitak’ in 
Turkey, ‘Euresearch’ in Switzerland, ‘Tekes’ in Finland. 
145 European Commission, CORDIS, About ISERD: retrieved on 04.05.2015: http://cordis.europa.eu/ 
israel/about_en.html. 
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ISERD was founded in the mid-90s when Israel accessed the EU in the framework 
of its 5th FP with the aim to serve as liaison between Israel and the FP.146 Concretely, 
ISERD is an  
inter-ministerial directorate, established by the Israeli Ministry of Economy, 
the Ministry of Science, Technology and Space, the Planning and Budgeting 
Committee of the Council for Higher Education, the Ministry of Finance and 
the Ministry of Foreign Affairs.147  
It is submitted to the Office of the 'Chief Scientist of the Ministry of the Economy'148 
(and not of the Ministry of Sciences as might be expected), which indicates the economic 
importance attributed to research cooperation by Israel. Its governance is assured via a 
‘Steering Committee’ regrouping representatives of the all the ministries mentioned 
above.149 ISERD’s rather surprisingly small staff of around 20 (visible) employees can rely 
on an efficient net of scientific structures. Each Israeli ministry can rely on the pro-active 
‘Office of the Chief Scientist’, a special department the Ministry of the Economy in charge 
of promoting R&D as well as industrial development in Israel.150 Israeli Universities are 
further oriented towards external cooperation via own ‘External Relations Divisions’, 
aiming at establishing cooperation with other actors.151 Regarding the hybrid nature of 
ISERD, it is interesting to observe a certain mutation of its definition. In 2006 ISERD 
mentioned explicitly its aim to “Promote Israel’s Interests at the European Commission 
and assuring that financing and projects are appropriate for Israeli organizations”.152 This 
definition has disappeared today. ISERD does not hide that it represents Israel in the 
management committees of the FP, but the reference to interest representation 
disappeared in favor of more emphasis on its task as NCP. This changing definition is 
conclusive insofar that it reflects the sui generis position of ISERD as a 'connector' 
between Israel and Europe. The headquarters of ISERD being in Tel-Aviv rather than in 
Brussels indicates that the main emphasis of ISERD lays in the promotion of the FPs to 
146 ISERD, Israel and the European Framework Programme for Research and Development 2007-
2013, retrieved on 04.05.2015: http://www.iserd.org.il/_Uploads/dbsAttachedFiles/ISERD.pdf, p. 29. 
147 ISERD Website, About ISERD, retrieved on 4.05.2015: http://www.iserd.org.il/ABOUT_ISERD. 
148 Ibidem.  
149 ISERD, ‘ISERD – Your port for FP Israel’, Presentation PPT, April 2013. 
150 Interview with Mr. Gil Mor, Mission of Israel to the EU, Minister-Counselor for Industry and Trade, 
Brussels, 1 April 2015. 
151 Ibidem. 
152 Israel and the European Framework Programme for Research and Development 2007-2013, op. 
cit., p. 29. 
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the Israeli scientific community rather than vice-versa. Nonetheless, this does not exclude 
a strong and regular presence in Brussels, where ISERD can rely on the support of the 
Israel-Mission to the European Union.153  
A wide range of responsibilities 
Via its crucial position between Brussels and Tel Aviv, representing and promoting 
Israeli research in Brussels, ISERD is the ‘nerve center’ of all channels of influences 
developed and analyzed in this section. Besides taking charge of the NCPs, ISERD assures 
the representation of Israel in the numerous EU governing bodies related to research 
(Programme Committee, Board of Governors etc.).   
Moreover, ISERD promotes actively a stronger presence of Israeli actors in EU 
associations, ETPs and expert groups of the Commission.154 ISERD underlines the benefits 
of memberships for the personal networks as well as for the creation of a general 
understanding of ‘what makes a good proposal’.155 Crucial for the construction of an 
effective collaboration, ISERD maintains connections to important platforms promoting 
exchanges among researcher and fostering the establishment of cross-border research 
cooperation. For example, in EUREKA and COST (European Cooperation in Science and 
Technology)156 Israel has a place in their governing bodies. Again, the representation of 
Israel is assured in these bodies via ISERD.157  
Concordant with the requirements set by the Commission for NCPs, ISERD 
underlines that it promotes the participation of Israeli entities in the FP158 and “actively 
assists academic and industrial entities in preparing and submitting their EU-RTD program 
proposals”.159 In order to prepare Israeli applicants for H2020 funding, ISERD organizes 
trainings on the specificities of European research policy and opportunities for funding. 
For more expertise, it even hires EU-Officials for training purposes.160 It further issues 
153 Interview with Mr. Gil Mor, Mission of Israel to the EU, Minister-Counselor for Industry and Trade, 
Brussels, 1 April 2015. 
154  ISERD, General Presentation: תלהנימה תילארשיה ומל"פ יפוריאה, retrieved on 5.05.2015: 
http://www.iserd.org.il/_Uploads/dbsAttachedFiles/iserd_orientation_presentation_150114.pdf. 
155 Ibidem.  
156 More information about EUREKA and COST under Annex II.  
157 Interview with an EU-Official, Council of the European Union, Brussels, 1 April  2015.  
158 ISERD Website, About ISERD, op. cit.  
159 European Commission, CORDIS, About ISERD: retrieved on 04.05.2015: http://cordis.europa.eu/ 
israel/about_en.html. 
160 ISERD-YouTube Channel, Training on the H2020 Participants Portal System by Peter Haertwich, 
Deputy Head of Unit, European Commission, retrieved on 4.05.2015: https://www.youtube.com/ 
watch?v=YqRnzE6_rCw. 
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guidelines and texts about good funding strategies, including recommendations and tips 
on how to win a strategy. These can be subscribed to in the form of ‘Weekly Orientation 
Presentations’.161 If needed, ISERD guides the applicants through the different steps of an 
application. 162  The website collects and advertises calls for funding or scientific 
opportunities and cooperation with other actors, which is important since certain calls 
require a consortium of many actors applying together.163 Special attention should be 
given to the ominous ‘Red Team’ in charge of overlooking and assessing proposals 
coming from Israeli actors before submitting them to the Commission.164 Going beyond 
the providing of advice and expertise, ISERD offers financial support to SME businesses 
willing to construct research cooperation in Europe. This information is slightly hidden on 
the English homepage behind a specific button only available in Hebrew.165 The button ‘ןרק 
עויס’ (Assistance Funds) leads to an online application form in Hebrew, with which the 
potential applicant can apply for SME Funding.166 ISERD takes its role very seriously, with 
a strong sense of competition.167 Indicative for its ambition is a counter installed on the 
ISERD homepage, informing readers about the “number of Israeli winners since 2014”.168 
The most successful projects are presented in ISERD publications.168F169  
All this support from ISERD helps effectively to overcome the administrative 
obstacles often deterring potential Israeli applicants who consider themselves to be 
“outside the EU funding system”.170 Assessing the impact of ISERD more generally, Prof. 
Dany Dolev, former member of the scientific board of the ERC, explains that it contributed 
to making research cooperation between Israel and Europe natural by raising the mutual 
161 ISERD – Bar Mitzwa, 13 Years of Success, Special Supplement to the Daily Newspaper ‘Haaretz’, 
retrieved on 5.05.2015: http://www.iserd.org.il/_Uploads/dbsAttachedFiles/Iserd_magazine_ 
English(1).pdf. 
162 ISERD Website, retrieved on 4.05.2015,  http://www.iserd.org.il/?CategoryID=179. 
163  ISERD Website, Open Calls, retrieved on 4.05.2015: http://www.iserd.org.il/Open_Calls_ 
Horizon2020. 
164 Interestingly, despite the whole presentation being in English, the information on the ‘Red Team’ 
is only provided in Hebrew: תוריש הקידבל תימדקמ לש תועצה םרטב ןתשגה תוביצנל, in: ISERD, Orientations 
Presentation, 9.02.2015, retrieved on 5.05.2015: http://www.iserd.org.il/_Uploads/ 
dbsAttachedFiles/Orientations_presentation_Master_090215.ppt. 
165 ISERD-Homepage, retrieved on 5.05.2015: http://www.iserd.org.il/. 
166 ISERD, Fund Application Form, ןרק עויסה תורבחל תונטק תוינוניבו תשגהל תועצה תינכתל, retrieved on 
5.05.2015: http://www.iserd.org.il/?CategoryID=175&ArticleID=563. 
167 Interview with Stephanie Horel, Expert in EU Funding management, Bruges, 6 May 2015.  
168 296 until 4 May 2015, see: ISERD-Homepage, op. cit.  
169 ISERD – Bar Mitzwa, 13 Years of Success, Special Supplement to the Daily Newspaper ‘Haaretz’, 
op. cit. 
170 ISERD Youtube-Channel, Zeevi Bregman at a Panel Discussion organized by ISERD, retrieved on 
4.05.2015: https://www.youtube.com/watch?v=lFMlQ6s68jw. 
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awareness of the research communities for each other.171 Even if a comparison between 
NCPs is difficult, the concentration of Israeli NCPs is very efficient in filling the identified 
‘gap’ between H2020 and the research community.  
ISERD’s key role can best be illustrated graphically. The following figure exposes all 
the links, formal or less formal ascertained between ISERD and European research-related 
actors. It shows the position of ISERD as the bottleneck between two important scientific 
areas between which it becomes the mediator.  
 
Figure3: ISERD: nerve center of Israeli influence on EU Research Policy172 
The decisive influence of Israel in the domain of European research policy can even be 
narrowed down to one person: ISERDs Director General Marcel Shaton, who has been 
involved in research cooperation between Israel and the EU since its beginning.173 He was 
171 ISERD-YouTube Channel, Prof. Dany Dolev at and ISERD Panel Discussion, retrieved on 
4.05.2015: https://www.youtube.com/watch?v=lFMlQ6s68jw. 
172 Own Compilation.  
173 ISERD, Israel and the European Framework Programme for Research and Development 2007-
2013, op. cit., p. 29. 
                                                 
mentioned by several interview subjects as being their most important Israeli contact 
person, sometimes also referring to him as the ‘key player’ of Israeli research interests in 
Brussels.174 Described as very ‘pro-active’ and always ‘between Israel and Brussels’,175 
Shaton can be considered as the discrete but effective conductor of the EU-Israeli 
research cooperation. 
 
Conclusion 
European research policy is a highly regulated domain, where decisions are made close to 
the scientific community (e.g. ETPs) and experts (e.g. advisory groups). Furthermore, 
biannual readjustments of European research policy via internal committees involve the 
MSEU and the associated states. Aiming at controlling and channeling external influence 
and expertise, these procedures represent ‘channels of influence’ for external interest. For 
Israel like for any other state, this means playing by the rules set by the institutions and 
following the ‘channels of influence’ identified in the model on research policy lobbying 
above. Since the elaboration of European research policy is a policy somehow ‘sui generis’, 
specific tools of analysis were required. The model on research policy lobbying becomes 
here a useful tool applicable for other actors hoping to gain influence in EU research 
policy.  
A first notable observation is the inability of the well-established Israeli-friendly 
forums and networks in Brussels to influence positively the issue of European research 
policy. Deprived of technical expertise and limited to the role of contact platforms and 
opinion shapers, their activity rather had a negative effect on Israeli interests in research. 
The asserted power of these bodies can be refuted with regard to EU research policy and 
questioned in relation to any more technical policy fields. Moreover, the determination of 
the Commission not to cede to Israeli pressure on the question of the H2020 accession of 
Israel further questions the statement of  David Cronin, accusing Europe of ‘cowardice’ and 
‘complicity’ towards Israel.176 
The most relevant ‘channels of influence’ identified for Israel's interest reside in the 
fact that Israel has the opportunity to act from within the research policy implementation 
system, via its specific forums of governance. Treated nearly the same as an MSEU, Israel 
174 Interview with an EU-Official, Brussels, 1 April 2015. 
175 Ibidem.  
176 D. Cronin, Europe-Israel: Une alliance contre-nature, Toulouse, La Guillotine 2012. 
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brings its concerns effectively onto the agenda. This is accompanied by the particular 
ability of Israel to ensure the implementation of the EU Research Policy at the national 
level via an effective organization of provided EU structures (‘National Contact Points’-
NCPs). The outstanding role is played here by the Israel-Europe R&D Directorate (ISERD), 
connecting efficiently all the relevant actors, forums and phases of EU-Israeli research 
policy. ISERD acts as bridge between Israel and the EU and is the heart of Israeli interest 
representation in the field of research in Europe. Discrete but transparent, the focus of 
ISERD is purely linked to research policy. Centralized NCPs, as embodied by ISERD, have a 
strong ability to connect and coordinate European and national interests in complicated 
and highly technical working field.  Bearing in mind that EU policies are generally criticized 
for being too far from the people, the role of centralized NCPs could become an example 
for other policies dealing with non-MSEU, like the European Neighborhood Policy (ENP) 
and the European enlargement.  
A lot of parallels between the ENP to the complex domain of European Research 
Policy can be drawn: 
• Complex administrative structures at EU-administration level 
• Large funds to disburse – related absorption problems 
• Target groups difficult to reach 
• High variations in the reliability of administrative structures on the ground 
• Information and coordination gaps 
Centralized NCPs following the dynamic example of ISERD could help in solving these 
problems, while offering numerous further advantages: 
• Respect of the ownership for the partner-country 
• Better supervision of decision making procedures for EU officials in the partner 
state  
• Creation of a network of ENP experts in partner states – expertise spillovers 
• Little administrative and financial costs for the Commission.  
Finally, the disclosed effectiveness of Israel in addressing research policy concerns 
at the European level is not free of a margin for improvement. Hence, the low presence of 
Israeli actors within associations and European Technology Platforms (ETPs) should be 
addressed. This would favor a natural networking and communication between European 
and Israeli research communities and thus ease the task of ISERD. It would further help to 
promote a European awareness of EU-Israeli research cooperation in general and favor a 
 39 
natural and beneficial transparence. Considering the important personal role played by 
ISERD Director General Marcel Shaton, who retired in the spring of 2015, it remains to be 
seen if Israel will be able to maintain its efficiency and be able to address the challenges 
to come. 
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Michael 
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Jean-
Pierre, 
Prof. 
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coordinator of FP7 EuCARD 
Personal Brussels 31.03.2015 
Lannon, 
Erwan 
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Ghent and the CoE. Expert in 
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Legris, 
Richard 
Former Official of the Council of 
the European Union and the 
Commission. Prepared and 
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Personal Bruges 28.03.2015 
Mor, Gil Mission of Israel to the EU, 
Minister-Counselor for Industry 
and Trade 
Personal  Brussels 1.04.2015 
Springhetti, 
Daniele 
European Research Council 
Executive Agency, Assistant to the 
head of department for Grant 
Management 
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Research Executive Agency, Head 
of Department Industrial 
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Challenges 
Phone Bruges 24.03.2015 
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Annexes 
 
 
ANNEX I: Overview of EU-R&I related actors177 
Institution Related Body/ Project 
European Commission - Joint Research Centre 
- DG Research and Innovation 
- Other relevant DGs 
- Framework Programmes (H2020) 
 
European Parliament - Committee on industry, research and 
energy 
 
Council of the European Union - COST (European Cooperation in 
Science and Technology) 
- Competitiveness: internal market, 
industry and research 
 
European Economic and Social Committee - Single Market, production and 
consumption 
 
Committee of the Regions - Commission for Education, youth, 
culture and research 
 
EU Agencies - Research Executive Agency (REA) 
- European Research Council Executive 
Agency (ERCEA) 
- Executive Agency for Small and 
Medium-sized Enterprises (EASME) 
- Innovation and Networks Executive 
Agency (INEA) 
177 Source: Own compilation, using: European Union, Research and Innovation Institutions and 
Bodies, retrieved on 27.04.2015: http://europa.eu/pol/rd/index_en.htm. 
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ANNEX II: List of the most relevant research related associations in Europe178 
Institution Type of Members Description (if 
necessary) 
Membership of 
Israel/ Israeli 
research actors 
AeroSpace and 
Defense Industries 
Association of 
Europe, ASD 
~25 National 
Aeronautic Defense 
Associations and 
Companies 
 No 
All European 
Academies, ALLEA 
58 National 
Academies of 
Sciences and 
Humanities in 40 
countries  
 Yes  (Israel 
Academy is a 
founding 
Member) 
Alliance for 
Materials, A4M 
A dozen national 
Research and 
Technology 
Organizations 
 No 
Association for 
European 
Nanoelectronic 
Activities, AENEAS 
~150 Businesses and 
Universities working 
on Nano-
Technologies 
 Yes,  
No Universities 
or Research 
Institutions 
Association of 
European 
Renewable Energy 
Research Centers, 
EUREC 
Representing 44 
research centers and 
university 
departments active in 
the area of renewable 
energy 
 No 
Association of 
European Research 
Establishments in 
Aeronautics, EREA 
Europe’s eleven most 
outstanding research 
centers active in the 
field of aeronautics 
and air transport 
 No  
CECIMO 15 national 
associations of 
machine tool builders, 
represents 
approximately 1500 
industrial enterprises 
in Europe and its 
Neighborhood 
 No 
  
178  Source: Own Compilation. Only associations and networks registered in the European 
Transparency Register (ETR) have been considered. The selection of relevant Associations and 
Networks was made according to their linkage to research or to a sector of Israeli Scientific 
specialization (Aeronautics, Medicine, Security, ICT). My selection was further guided by the 
qualitative advice of interviewees. 
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Conference of 
European Schools 
for advanced 
research education 
and research, 
CESAER 
More than 50 leading 
European universities 
engaged in advanced 
engineering 
education and 
research and 
dedicated to research 
 Yes 
From Israel 
only the 
Technion – 
Israel Institute 
for Technology 
is a member. 
This is few 
compared to 
other countries. 
DigitalEurope 30 National ICT 
associations and 
more than 50 leading 
ICT Corporations 
 No 
EBN Innovation 
Network 
 
~ 150 Business and 
innovation centers in 
40 countries (Mainly 
in Europe and its 
Neighborhood) 
 No 
EU Robotics AISBL 236 Universities and 
businesses 
specialized in 
robotics 
 No 
EurAqua 24 leading institutes 
in water research in 
Europe and 
Associated Countries 
Research Network of 
Freshwater 
Organisations 
No,  
EUREKA 41 Countries Member 
or Associated to 
H2020. 
“an intergovernmental 
initiative, EUREKA aims 
to enhance industrial 
competitiveness 
through its support to 
businesses, research 
centers and 
universities who carry 
out pan-European 
projects to develop 
innovative products, 
processes and 
services”179 
Yes 
European 
Aeronautics 
Sciences Network, 
EASN 
~40 European 
Countries, listing 
relevant Institutions 
and contact Persons 
related to the topic 
 Yes 
But strangely 
no names or 
Associations 
are listed in the 
Database 
179  Matimop Website, Israeli Industry Center for R&D, retrieved on 2.05.2015: 
http://www.matimop.org.il/eureka.html. 
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European 
Association for 
Cancer Research, 
EACR 
Leading National 
Societies involved in 
Cancer Research 
 Yes 
European 
Association of 
Development 
Agencies, EURADA 
~70 Regional 
development 
Agencies 
Lobbies and briefs the 
Commission, build 
networks. Focused on 
economic development 
with a focus on 
Innovation 
No 
European 
Association of 
Institutions in 
Higher Education, 
EURASHE 
~60 Higher Education 
Institutions and 
Universities 
 No 
European 
Association of 
National Research 
Facilities, ERF 
~15 European 
scientific research 
facilities  
 No 
European 
Association of 
Research and 
Technology 
Association, EARTO 
Around 80 Research 
and Technology 
Organizations from 
MSEU or Associated 
States to H2020 
“promote and defend 
the interests of RTOs in 
Europe by reinforcing 
their profile and 
position as a key player 
in the minds of EU 
decision-makers and 
by seeking to ensure 
that European R&D and 
innovation 
programmes are best 
attuned to their 
interests”180 
No 
European 
Biopharmaceutical 
Enterprises, EBE 
~30 Pharmaceutical 
enterprises 
 No 
European 
Cooperation in 
Sciences and 
Technology, COST 
35 MSEU and 
Neighborhood states  
“COST is the longest-
running European 
framework supporting 
trans-national 
cooperation among 
researchers, engineers 
and scholars across 
Europe.”181  
Note: COST is funded 
to 100% via the FP of 
the EU. 
Yes 
Israel is the 
only Member 
with the 
restricted 
status of a 
‘Cooperating 
State’.  
180 EARTO Website, About EARTO, retrieved on 1.05.2015: http://www.earto.eu/about-earto.html. 
181 COST Website, http://www.cost.eu/about_cost. 
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European 
Federation of 
Pharmaceutical 
Industries and 
Associations, EFPIA 
40 Leading 
Pharmaceutical 
Enterprises 
 No 
European Regions 
Research and 
Innovation Network, 
ERRIN 
“a dynamic network 
of, currently, more 
than 90 European 
regions and their 
Brussels-based EU 
offices.”182 It is Open 
to Associated States. 
“facilitates knowledge 
exchange, joint action 
and project 
partnerships between 
its members with the 
aim to strengthen their 
region's research and 
innovation 
capacities”183 
No 
European Sciences 
Foundation, ESF 
75 National Sciences 
Organizations in 30 
countries 
“stimulating European 
research through its 
networking and 
coordination 
activities”184 
Yes,  
Observer 
Status 
European 
Universities 
Association, EUA 
850 Universities and 
Research Institutions 
are Member in 47 
Countries in Europe 
and its Neighborhood 
 No  
Very surprising. 
Even the Holy 
See and 
Andorra are 
Members 
Federation of 
European 
Neuroscience 
Societies, FENS 
~50 National 
Neurosciences 
Societies 
 Yes 
League of European 
Research 
Universities, LERU 
12 leading European 
Research Universities 
“consortium of some of 
the most renowned 
research universities in 
Europe”185 
No 
  
182 ERRIN Website, About Us, retrieved on 2.05.2015: http://www.errin.eu/content/about-us-0. 
183 Ibidem. 
184  European Sciences Foundation, Recent Developments, retrieved on 28.04.2015: 
http://www.esf.org/esf-today/recent-developments.html. 
185  LERU Website, retrieved on 28.04.2015: http://www.leru.org/index.php/public/about-
leru/members/. 
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Partnership of a 
European Group of 
Aeronautics and 
Space Universities, 
PEGASUS 
~10 Universities and 
Research Institutes 
leading in 
Aeronautics 
 No 
Vision 2020: The 
Horizon Network 
Numerous National 
Universities and 
innovating  
businesses 
”Vision2020 acts as a 
hub to connect Horizon 
2020 participants from 
excellent universities 
and innovative 
companies, and works 
to maximize the value 
and Horizon 2020 
funding its members 
can obtain”186 
Yes.  
From Israel 
only Bar Ilan 
University is in 
the Network. 
This is few 
compared to 
other countries. 
186 Vision 2020 Website, retrieved on 1.05.2015: http://2020visionnetwork.eu/. 
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ANNEX III: Membership of Israeli Experts in Advisory Groups187 
Advisory Group 
Membership of 
Israeli Expert 
Access to risk finance (debt and equity financing) Yes 
Climate action, environment, resource efficiency and raw materials No 
European research infrastructures including eInfrastructures Yes 
Europe in a changing world – inclusive, innovative and reflective 
societies 
No 
Food security, sustainable agriculture and forestry, marine and 
maritime and inland water research and the bioeconomy and 
biotechnology 
No 
Future and Emerging Technologies (FET) Yes 
Gender Yes 
Health, demographic change and wellbeing No 
Innovation in small and medium-sized enterprises (SMEs) No 
International cooperation No 
The Marie Skłodowska-Curie actions on skills, training and career 
development 
No 
Nanotechnologies, advanced materials and advanced manufacturing 
and processing 
Yes 
Science with and for Society No 
Secure, clean and efficient energy and Euratom No 
Secure societies – protecting freedom and security of Europe and its 
citizens 
Yes 
Smart, green and integrated transport No 
Space No 
Spreading excellence and widening participation No 
 
  
187 Source: Own research and compilation using Data provided by the European Commission on its 
Register of Expert Groups, see: European Commission, Register of Commission Expert Groups, 
retrieved on 3.05.2015: http://ec.europa.eu/transparency/regexpert/.  
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ANNEX IV: Israeli Membership in European Technology Platforms (ETPs)188 
ETP 
 
Membership of Israel/Israeli Actor 
Advisory Council for Aviation Research and 
Innovation in Europe (ACARE) 
No (Surprising) 
Association for R&D actors in Embedded Systems 
(ARTEMIS) 
No (Surprising) 
European Aquaculture Technology and Innovation 
Platform (EATIP) 
No  
European Biofuels Technology Platform (EBTP) No 
European Construction Technology Platform (ECTP) No 
European Photovoltaic Technology Platform (EU PV 
TP) 
No 
European Rail Research Advisory Council (ERRAC) No 
European Road Transport Research Advisory 
Council (ERTRAC) 
No 
European Robotics Technology Platform 
(EUROP/euRobotics) 
Yes (Israel Aerospace Industries and 
Technion Institute Haifa) 
European Steel Technology Platform (ESTEP) - 
European Technology Platform for Advanced 
Engineering Materials (EuMaT) 
- 
European Technology Platform for Global Animal 
Health (ETPGAH) 
No 
European Technology Platform for High 
Performance Computing (ETP4HPC) 
No 
European Technology Platform for Nanoelectronics 
(ENIAC) 
Yes 
European Technology Platform for the Future of 
Textiles and Clothing 
No 
188 Source: Own research and compilation using Data from the European Commission, see: European 
Commission, European Technology Platforms, retrieved on 3.05.2015: http://ec.europa.eu/research/innovation-
union/index_en.cfm?pg=etp. 
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European Technology Platform for Sustainable 
Chemistry (SusChem) 
- 
European Technology Platform for Wind Energy 
(TPWind) 
- 
European Technology Platform on Logistics No 
European technology Platform on Nanomedicine Yes 
European Technology Platform on Renewable 
Heating & Cooling (RHC-Platform) 
No 
European Technology Platform on Smart Systems 
Integration (EPoSS) 
No 
European Technology Platform on Sustainable 
Mineral Resources (ETP-SMR) 
No 
Food for Live Yes 
Forest Based Sector Technology Platform - 
Integral Satcom Initiative (ISI) Yes 
Manufuture No 
Net!Works Yes (32 Members!) 
Networked and Electronic Media (NEM) No 
Networked European Software and Services 
Initiative (NESSI) 
Yes 
Photonics 21 Yes (Among other ISERD!) 
Plants for the Future Yes 
Smart Grids European Technology Platform No 
Sustainable Farm Animal Breeding and 
Reproduction Technology Platform (FABRE-TP) 
Yes 
Sustainable Nuclear Energy Technology Platform 
(SNETP) 
No 
Technology Research Platform for organic food and 
farming (TP Organics) 
Yes 
Water supply and sanitation Technology Platform 
(WssTP) 
Yes 
 55 
Waterborne No 
Zero Emissions Platform (ZEP) No 
Cross ETP Initiatives:  
Nanofutures Yes 
Industrial Safety - 
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Europe is in a constant state of flux. European politics, economics, law and indeed 
European societies are changing rapidly. The European Union itself is in a continuous 
situation of adaptation. New challenges and new requirements arise continually, both 
internally and externally.  
The College of Europe Studies series seeks to publish research on these issues done 
at the College of Europe, both at its Bruges and its Natolin (Warsaw) campus. Focused on 
the European Union and the European integration process, this research may be 
specialised in the areas of political science, law or economics, but much of it is of an 
interdisciplinary nature. The objective is to promote understanding of the issues 
concerned and to make a contribution to ongoing discussions. 
 
L’Europe subit des mutations permanentes. La vie politique, l’économie, le droit, 
mais également les sociétés européennes, changent rapidement. L’Union européenne 
s’inscrit dès lors dans un processus d’adaptation constant. Des défis et des nouvelles 
demandes surviennent sans cesse, provenant à la fois de l’intérieur et de l’extérieur. 
La collection des Cahiers du Collège d’Europe publie les résultats des recherches 
menées sur ces thèmes au Collège d’Europe, au sein de ses deux campus (Bruges et 
Varsovie). Focalisés sur l’Union européenne et le processus d’intégration, ces travaux 
peuvent être spécialisés dans les domaines des sciences politiques, du droit ou de 
l’économie, mais ils sont le plus souvent de nature interdisciplinaire. La collection vise à 
approfondir la compréhension de ces questions complexes et contribue ainsi au débat 
européen. 
 63 
  
 64 
Series Titles: 
 
vol. 18 Schunz, Simon, European Union Foreign Policy and the Global Climate Regime, 
2014 (371 p.), ISBN 978-2-87574-134-9 pb, 978-3-0352-6409-8 (eBook) 
vol. 17 Govaere, Inge / Hanf, Dominik (eds.), Scrutinizing Internal and External Dimensions of 
European Law volumes I and II, 2013 (880 p.), ISBN 978-2-87574-085-4 pb, ISBN 978-3-0352-
6342-8 (eBook)  
vol. 16 Chang, Michele / Monar, Jӧrg (eds.), The European Commission in the Post-Lisbon Era 
of Crises: Between Political Leadership and Policy Management, 2013 (298 p.), ISBN 978-2-
87574-028-1 pb, ISBN 978-3-0352-6294-0 (eBook) 
vol. 15 Mahnke, Dieter / Gstӧhl, Sieglinde (eds.), European Union Diplomacy: Coherence, 
Unity and Effectiveness, 2012 (273 p.) ISBN 978-90-5201-842-3 pb, ISBN 978-3-0352-6172-1 
(eBook) 
vol. 14 Lannon, Erwan (ed.), The European Neighborhood Policy’s Challenges, 2012 (491p.), 
ISBN 978-90-5201-779-2 pb, ISBN 978-3-0352-6104-2 (eBook) 
vol. 13 Cremona, Marise / Monar, Jörg / Poli Sara (eds.), The External Dimension of the 
European Union’s Area of Freedom, Security and Justice, 2011 (432 p.), ISBN 978-90-5201-
728-0 pb, ISBN 978-3-0352-6107-3 (eBook) 
vol. 12 Men, Jong / Balducci, Giuseppe (eds.), Prospects and Challenges for EU-China 
Relations in the 21st Century, 2010 (262 p.), ISBN 978-90-5201-641-2 pb. 
vol. 11 Monar, Jörg (ed.), The Institutional Dimension of the European Union’s Area of 
Freedom, Security and Justice, 2010 (268 p.), ISBN 978-90-5201-615-3 pb. 
vol. 10 Hanf, Dominik / Malacek, Klaus / Muir, elise (eds.), Langues et construction 
européenne, 2010 (286 p.), ISBN 978-90-5201-594-1 pb.  
vol. 9 Pelkmans, Jacques / Hanf, Dominik / Chang, Michele (eds.), The EU Internal Market in 
Comparative Perspective,  2008 (314 p.), ISBN 978-90-5201-424-1 pb.  
vol. 8 Govaere, Inge / Ullrich, Hanns (eds.), Intellectual Property, Market Power and the Public 
Interest, 2008 (315 p.), ISBN 978-90-5201-422-7 pb. 
vol. 7 Inotai, András, The European Union and Southeastern Europe: Troubled Waters Ahead?, 
2007 (414 p.), ISBN 978-90-5201-071-7 pb. 
vol. 6 Govaere, Inge / Ullrich, Hanns (eds.), Intellectual Property, Public Policy, and 
International Trade, 2007 (232 p.), ISBN 978-90-5201-064-9 pb. 
 65 
vol. 5 Hanf, Dominik / Muñoz, Rodolphe (eds.), La libre circulation des personnes: États des 
lieux et perspectives, 2007 (329 p.), ISBN 978-90-5201-061-8 pb. 
vol. 4 Mahncke, Dieter / Gstöhl, Sieglinde (eds.), Europe's Near Abroad: Promises and 
Prospects of the EU's Neighbourhood Policy, 2008 (316 p.), ISBN 978-90-5201-047-2. 
vol. 3 Mahncke, Dieter / Monar, Jörg (eds.), International Terrorism: A European Response to 
a Global Threat? 2006 (191p.), ISBN 978-90-5201-046-5 / US-ISBN 978-0-8204-6691-0 pb. 
vol. 2 Demaret, Paul / Govaere, Inge / Hanf, Dominik (eds.), European Legal Dynamics - 
Dynamiques juridiques européennes, Revised and updated edition of 30 Years of European 
Legal Studies at the College of Europe, 2005 / 2007 (571 p.), ISBN 978-90-5201-067-0 pb. 
vol. 1 Mahncke, Dieter / Ambos, Alicia / Reynolds, Christopher (eds.), European Foreign 
Policy: From Rhetoric to Reality?, 2004 / second printing 2006 (381 p.), ISBN 978-90-5201-
247-6 / US-ISBN 978-0-8204-6627-9 pb.  
 
 
 
 
If you would like to be added to the mailing list and be informed of new publications and 
department events, please email rina.balbaert@coleurope.eu. Or find us on Facebook: 
www.facebook.com/coepol  
 
 
 
 66 
